Health ❯ Healthcare ❯ Diseases
Alzheimer's Disease Guillain-Barré Syndrome Multiple Sclerosis Parkinson's Disease Amyotrophic Lateral Sclerosis Guillain-Barre Syndrome Stroke Alzheimer’s Disease Motor Neuron Diseases Amyotrophic Lateral Sclerosis (ALS) Huntington's Disease Frontotemporal Dementia ALS Migraines
The program narrows to non‑relapsing secondary progressive MS, with the U.S. decision now expected by the end of the first quarter of 2026.